Suppr超能文献

SIRT6:皮肤癌研究的新起点

The sirtuin 6: An overture in skin cancer.

机构信息

Department of Dermatology, University of Wisconsin, Madison, WI, USA.

William S. Middleton VA Medical Center, Madison, WI, USA.

出版信息

Exp Dermatol. 2020 Feb;29(2):124-135. doi: 10.1111/exd.14057. Epub 2019 Dec 29.

Abstract

In the recent past, the sirtuins have been under intense investigation for their roles in biology and disease, including cancer. The sirtuin SIRT6 is comparatively a lesser studied member of this family of seven proteins. Like certain other sirtuins, SIRT6 is emerging to have an oncogenic function as well as tumor suppressor roles in cancer. Limited studies have been conducted assessing the role and functional significance of SIRT6 in melanoma and non-melanoma skin cancers. In this review, we have attempted to critically dissect the potential role and significance of SIRT6 in skin carcinogenesis. With limited available information to date, SIRT6 appears to have a pro-proliferative function in non-melanoma skin cancers (NMSCs), including squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). In addition, SIRT6 is also emerging to have an oncogenic function in melanoma. Moreover, we have provided information regarding the available SIRT6 inhibitors. Conclusively, it appears that additional comprehensive studies are needed to establish the role of SIRT6 in skin biology and skin diseases, including cancer. Further, concerted efforts are needed to characterize the stage-specific role of SIRT6 in skin cancers.

摘要

在最近的过去,沉默调节蛋白一直是生物学和疾病(包括癌症)研究的热点。沉默调节蛋白 SIRT6 相对来说是这个由 7 种蛋白质组成的家族中研究较少的成员。与某些其他沉默调节蛋白一样,SIRT6 在癌症中具有致癌功能和肿瘤抑制作用。目前已经进行了一些有限的研究来评估 SIRT6 在黑色素瘤和非黑色素瘤皮肤癌中的作用和功能意义。在这篇综述中,我们试图批判性地剖析 SIRT6 在皮肤癌发生中的潜在作用和意义。由于目前可用的信息有限,SIRT6 似乎在非黑色素瘤皮肤癌(NMSC)中具有促增殖作用,包括鳞状细胞癌(SCC)和基底细胞癌(BCC)。此外,SIRT6 在黑色素瘤中也具有致癌作用。此外,我们还提供了有关可用的 SIRT6 抑制剂的信息。总之,似乎需要进行更多全面的研究来确定 SIRT6 在皮肤生物学和皮肤疾病(包括癌症)中的作用。此外,需要共同努力来描述 SIRT6 在皮肤癌中的特定阶段作用。

相似文献

1
The sirtuin 6: An overture in skin cancer.
Exp Dermatol. 2020 Feb;29(2):124-135. doi: 10.1111/exd.14057. Epub 2019 Dec 29.
2
UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
Adv Exp Med Biol. 2017;996:27-40. doi: 10.1007/978-3-319-56017-5_3.
3
Sirtuins and SIRT6 in Carcinogenesis and in Diet.
Int J Mol Sci. 2019 Oct 7;20(19):4945. doi: 10.3390/ijms20194945.
5
SIRT6 promotes COX-2 expression and acts as an oncogene in skin cancer.
Cancer Res. 2014 Oct 15;74(20):5925-33. doi: 10.1158/0008-5472.CAN-14-1308.
6
SIRT6 Is a Target of Regulation by UBE3A That Contributes to Liver Tumorigenesis in an ANXA2-Dependent Manner.
Cancer Res. 2018 Feb 1;78(3):645-658. doi: 10.1158/0008-5472.CAN-17-1692. Epub 2017 Dec 7.
7
Non-Melanoma Skin Cancers: Biological and Clinical Features.
Int J Mol Sci. 2020 Jul 29;21(15):5394. doi: 10.3390/ijms21155394.
8
Expression of RUNX3 in skin cancers.
Clin Exp Dermatol. 2011 Oct;36(7):769-74. doi: 10.1111/j.1365-2230.2011.04069.x. Epub 2011 May 30.
9
CRISPR/Cas9-mediated Knockout of SIRT6 Imparts Remarkable Antiproliferative Response in Human Melanoma Cells in vitro and in vivo.
Photochem Photobiol. 2020 Nov;96(6):1314-1320. doi: 10.1111/php.13305. Epub 2020 Jul 24.
10
High numbers of human skin cancers express MMP2 and several integrin genes.
J Cutan Pathol. 2008 Mar;35(3):285-91. doi: 10.1111/j.1600-0560.2007.00810.x.

引用本文的文献

1
Comprehensive pan-cancer analysis reveals SIRT5 is a predictive biomarker for prognosis and immunotherapy response.
Funct Integr Genomics. 2024 Mar 19;24(2):60. doi: 10.1007/s10142-024-01338-7.
2
The Role of NAD+, SIRTs Interactions in Stimulating and Counteracting Carcinogenesis.
Int J Mol Sci. 2023 Apr 27;24(9):7925. doi: 10.3390/ijms24097925.
3
The role of sirtuins in dermal fibroblast function.
Front Med (Lausanne). 2023 Mar 13;10:1021908. doi: 10.3389/fmed.2023.1021908. eCollection 2023.
4
Anti-aging Strategies and Topical Delivery of Biopolymer-based Nanocarriers for Skin Cancer Treatment.
Curr Aging Sci. 2024;17(1):31-48. doi: 10.2174/1874609816666230320122018.
6
A Novel Autophagy-Related lncRNA Gene Signature to Improve the Prognosis of Patients with Melanoma.
Biomed Res Int. 2021 Jun 18;2021:8848227. doi: 10.1155/2021/8848227. eCollection 2021.
7
Skin epigenetics.
Exp Dermatol. 2021 Aug;30(8):1004-1008. doi: 10.1111/exd.14418. Epub 2021 Jul 5.
8
The Two-Faced Role of SIRT6 in Cancer.
Cancers (Basel). 2021 Mar 8;13(5):1156. doi: 10.3390/cancers13051156.
9
Sirtuin 1 and Sirtuin 3 in Granulosa Cell Tumors.
Int J Mol Sci. 2021 Feb 19;22(4):2047. doi: 10.3390/ijms22042047.
10
Emerging roles of SIRT6 in human diseases and its modulators.
Med Res Rev. 2021 Mar;41(2):1089-1137. doi: 10.1002/med.21753. Epub 2020 Dec 16.

本文引用的文献

1
SIRT6 abrogation promotes adrenocortical carcinoma through activation of NF-κB signaling.
Mol Cell Biochem. 2019 Aug;458(1-2):1-10. doi: 10.1007/s11010-019-03525-8. Epub 2019 Apr 15.
2
SIRT6 inhibits proliferation and invasion in osteosarcoma cells by targeting N-cadherin.
Oncol Lett. 2019 Jan;17(1):1237-1244. doi: 10.3892/ol.2018.9676. Epub 2018 Nov 8.
3
Cancer statistics, 2019.
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
4
5
Melanoma.
Lancet. 2018 Sep 15;392(10151):971-984. doi: 10.1016/S0140-6736(18)31559-9.
6
7
Metastatic Melanoma: Recent Therapeutic Progress and Future Perspectives.
Drugs. 2018 Aug;78(12):1197-1209. doi: 10.1007/s40265-018-0945-z.
8
Sirtuin 6 inhibits colon cancer progression by modulating PTEN/AKT signaling.
Biomed Pharmacother. 2018 Oct;106:109-116. doi: 10.1016/j.biopha.2018.06.070. Epub 2018 Jun 26.
10
SIRT6 inhibits colorectal cancer stem cell proliferation by targeting CDC25A.
Oncol Lett. 2018 Apr;15(4):5368-5374. doi: 10.3892/ol.2018.7989. Epub 2018 Feb 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验